1. Home
  2. CUE vs ALTS Comparison

CUE vs ALTS Comparison

Compare CUE & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • ALTS
  • Stock Information
  • Founded
  • CUE 2014
  • ALTS 1976
  • Country
  • CUE United States
  • ALTS United States
  • Employees
  • CUE N/A
  • ALTS N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • ALTS
  • Sector
  • CUE Health Care
  • ALTS
  • Exchange
  • CUE Nasdaq
  • ALTS NYSE
  • Market Cap
  • CUE 60.6M
  • ALTS 61.2M
  • IPO Year
  • CUE 2018
  • ALTS N/A
  • Fundamental
  • Price
  • CUE $0.76
  • ALTS $5.15
  • Analyst Decision
  • CUE Strong Buy
  • ALTS
  • Analyst Count
  • CUE 3
  • ALTS 0
  • Target Price
  • CUE $3.00
  • ALTS N/A
  • AVG Volume (30 Days)
  • CUE 206.6K
  • ALTS 159.6K
  • Earning Date
  • CUE 05-08-2025
  • ALTS 05-02-2025
  • Dividend Yield
  • CUE N/A
  • ALTS N/A
  • EPS Growth
  • CUE N/A
  • ALTS N/A
  • EPS
  • CUE N/A
  • ALTS N/A
  • Revenue
  • CUE $9,287,000.00
  • ALTS $12,532,000.00
  • Revenue This Year
  • CUE N/A
  • ALTS N/A
  • Revenue Next Year
  • CUE $4.77
  • ALTS N/A
  • P/E Ratio
  • CUE N/A
  • ALTS N/A
  • Revenue Growth
  • CUE 69.16
  • ALTS N/A
  • 52 Week Low
  • CUE $0.45
  • ALTS $1.29
  • 52 Week High
  • CUE $2.26
  • ALTS $7.75
  • Technical
  • Relative Strength Index (RSI)
  • CUE 39.49
  • ALTS 58.72
  • Support Level
  • CUE $0.72
  • ALTS $3.58
  • Resistance Level
  • CUE $0.89
  • ALTS $4.14
  • Average True Range (ATR)
  • CUE 0.10
  • ALTS 0.60
  • MACD
  • CUE 0.02
  • ALTS 0.09
  • Stochastic Oscillator
  • CUE 48.59
  • ALTS 90.66

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.

Share on Social Networks: